questions for the clever ones here. I'm new to biotechs, so excuse my ignorance.
what type of money values are we looking at for licensing?
did you get a feel that the CellPryme-M technique required specialty (read expensive) equipment to perform(which may also be monetisable) or can it be performed by any lab involved in CAR-T with "standard" CAR-T tech.
DZ
questions for the clever ones here. I'm new to biotechs, so...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.001(1.92%) |
Mkt cap ! $42.68M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.4¢ | 5.2¢ | $21.85K | 418.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25086 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 8500 | 1 |
View Market Depth
| Last trade - 10.48am 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
5.3¢ |
Change
0.001 ( 1.92 %) |
||||
| Open | High | Low | Volume | ||
| 5.3¢ | 5.3¢ | 5.2¢ | 37682 | ||
| Last updated 11.01am 30/04/2024 ? | |||||
| PTX (ASX) Chart |